[Test of the efficacy of low-molecular tetanus antitoxin]

Area of Science:

• Immunology
• Pharmacology
• Neuroscience

Background:

• Tetanus intoxication poses a significant health risk, necessitating effective antitoxin therapies.
• Understanding the comparative efficacy of different tetanus antitoxin formulations is crucial for optimizing treatment strategies.
• Diaferm-3 and its Fabragment derivatives represent potential therapeutic options for tetanus.

Purpose of the Study:

• To compare the therapeutic efficacy of tetanus antitoxin Diaferm-3 and its Fabragment derivatives.
• To evaluate the effectiveness of these treatments at different stages of experimental tetanus intoxication.
• To determine the optimal administration routes for each formulation.

Main Methods:

• Experimental tetanus intoxication was induced in rabbits, white rats, and mice.
• The efficacy of tetanus antitoxin Diaferm-3 and its Fabragment derivatives was assessed.
• Different administration routes, including intracarotid and intracisternal injections, were investigated.

Main Results:

• Tetanus antitoxin Fabragments demonstrated higher efficacy in the early stages of experimental tetanus intoxication.
• High doses and intracarotid administration of Fabragments showed partial effectiveness.
• Intracisternal injection of the complete tetanus antitoxin Diaferm-3 proved most effective for treating established intoxication.

Conclusions:

• Tetanus antitoxin Fabragments offer a promising therapeutic approach for early-stage tetanus.
• The choice of antitoxin formulation and administration route should be tailored to the stage of tetanus intoxication.
• Intracisternal administration of Diaferm-3 is the most effective strategy for managing advanced tetanus symptoms.